These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 1997649)

  • 21. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):323-4. PubMed ID: 1990544
    [No Abstract]   [Full Text] [Related]  

  • 22. Peptidyl-prolyl cis-trans isomerase from Bacillus subtilis. A prokaryotic enzyme that is highly sensitive to cyclosporin A.
    Herrler M; Bang H; Brune K; Fischer G; Marahiel MA
    FEBS Lett; 1992 Sep; 309(3):231-4. PubMed ID: 1516692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages.
    Sherry B; Yarlett N; Strupp A; Cerami A
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3511-5. PubMed ID: 1565646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of immunosuppression.
    Baumann G; Zenke G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH
    J Autoimmun; 1992 Apr; 5 Suppl A():67-72. PubMed ID: 1380246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solution structure of the cyclosporin A/cyclophilin complex by NMR.
    Thériault Y; Logan TM; Meadows R; Yu L; Olejniczak ET; Holzman TF; Simmer RL; Fesik SW
    Nature; 1993 Jan; 361(6407):88-91. PubMed ID: 8421500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues.
    Durette PL; Boger J; Dumont F; Firestone R; Frankshun RA; Koprak SL; Lin CS; Melino MR; Pessolano AA; Pisano J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):51-7. PubMed ID: 2966482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nuclear RNA-binding cyclophilin in human T cells.
    Mi H; Kops O; Zimmermann E; Jäschke A; Tropschug M
    FEBS Lett; 1996 Dec; 398(2-3):201-5. PubMed ID: 8977107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression.
    Helekar SA; Patrick J
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5432-7. PubMed ID: 9144255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of cyclophilin A and cyclophilin C mRNA in murine kidney using RT-PCR.
    Otsuka M; Terada Y; Yang T; Nonoguchi H; Tomita K; Marumo F
    Kidney Int; 1994 May; 45(5):1340-5. PubMed ID: 8072246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A.
    Ke H; Mayrose D; Belshaw PJ; Alberg DG; Schreiber SL; Chang ZY; Etzkorn FA; Ho S; Walsh CT
    Structure; 1994 Jan; 2(1):33-44. PubMed ID: 8075981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity.
    Hong F; Lee J; Piao YJ; Jae YK; Kim YJ; Oh C; Seo JS; Yun YS; Yang CW; Ha J; Kim SS
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1073-80. PubMed ID: 15044094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidyl-prolyl cis-trans isomerase of Bacillus subtilis: identification of residues involved in cyclosporin A affinity and catalytic efficiency.
    Göthel SF; Herrler M; Marahiel MA
    Biochemistry; 1996 Mar; 35(11):3636-40. PubMed ID: 8639516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activation.
    Ryffel B; Woerly G; Quesniaux VF; Husi H; Foxwell BM
    Biochem Pharmacol; 1992 Mar; 43(5):953-60. PubMed ID: 1554393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bradykinin and its Gly6 analogue are substrates of cyclophilin: a fluorine-19 magnetization transfer study.
    London RE; Davis DG; Vavrek RJ; Stewart JM; Handschumacher RE
    Biochemistry; 1990 Nov; 29(45):10298-302. PubMed ID: 2261473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase.
    Steinmann B; Bruckner P; Superti-Furga A
    J Biol Chem; 1991 Jan; 266(2):1299-303. PubMed ID: 1985948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular targets of cyclosporine.
    Fairley JA
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1329-32; discussion 1332-4. PubMed ID: 2277142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate.
    Rosen MK; Standaert RF; Galat A; Nakatsuka M; Schreiber SL
    Science; 1990 May; 248(4957):863-6. PubMed ID: 1693013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
    J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solution conformation of a cyclophilin-bound proline isomerase substrate.
    Kakalis LT; Armitage IM
    Biochemistry; 1994 Feb; 33(6):1495-501. PubMed ID: 8312269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.